Topos Bio
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $10.5Mattributed |
|---|---|
| Latest round | seed, $10.5M, 2026-01-08attributed |
| Founded | 2024 |
| Headquarters | San Francisco, US |
| Industry | biotech |
| Stage | seed |
| Website | toposbio.ai |
AI-native drug discovery platform modeling intrinsically disordered protein ensembles for Alzheimer's and cancer targets.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-01-08 | seed | $10.5M | undisclosed |
Detected tech stack
Vercel, Google Analytics, Google Tag Manager, DoubleClick Floodlight, WordPress, PHP, MySQL, Astro
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $10.5M | attributed | news-misc named as publisher. No document URL on file. |
| Total raised $10.5M | attributed | news-misc named as publisher. No document URL on file. |
| Company existence | self-reported | toposbio.ai, read 2026-05-08 |
| Description | self-reported | toposbio.ai, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.